Sutro Biopharma (NASDAQ:STRO – Get Free Report) was downgraded by research analysts at Wedbush from an “outperform” rating to a “neutral” rating in a research note issued on Friday, MarketBeat.com ...
Tempest Therapeutics (NASDAQ:TPST – Get Free Report) is anticipated to issue its quarterly earnings data before the market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results